Meag Munich Ergo’s Bausch Health BHC Stock Holding History

Meag Munich Ergo’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-17,000	Closed	-$424K	–	344
2018 Q3	$424K	Buy	17,000 +7,000	+70%	+$160K	0.03%	353
2018 Q2	$236K	Buy	+10,000	New	+$207K	0.01%	357
2016 Q4	–	Sell	-55,000	Closed	-$1.39M	–	282
2016 Q3	$1.39M	Hold	55,000	–	–	0.07%	200
2016 Q2	$1.11M	Buy	+55,000	New	+$1.56M	0.1%	126
2016 Q1	–	Sell	-74,000	Closed	-$7.69M	–	241
2015 Q4	$7.69M	Buy	74,000 +200	+0.3%	+$22.5K	0.39%	89
2015 Q3	$12.7M	Buy	73,800 +4,600	+7%	+$1.07M	0.68%	45
2015 Q2	$15.3M	Hold	69,200	–	–	0.79%	37
2015 Q1	$13.9M	Sell	69,200 -55,800	-45%	-$9.9M	0.66%	51
2014 Q4	$17.7M	Hold	125,000	–	–	0.8%	36
2014 Q3	$16.3M	Buy	125,000 +12,000	+11%	+$1.43M	0.75%	41
2014 Q2	$14.3M	Buy	113,000 +20,500	+22%	+$2.62M	0.62%	52
2014 Q1	$12M	Buy	92,500 +10,500	+13%	+$1.44M	0.89%	33
2013 Q4	$9.54M	Hold	82,000	–	–	0.56%	55
2013 Q3	$8.6M	Buy	82,000 +9,000	+12%	+$877K	0.6%	61
2013 Q2	$6.97M	Buy	+73,000	New	+$5.75M	0.53%	67

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Meag Munich Ergo's BHC Position: Q4 2018 in Review

Meag Munich Ergo sold out of Bausch Health (BHC) in Q4 2018, closing a stake of 17,000 shares — an estimated $424K sold.

Meag Munich Ergo first reported a position in BHC in Q2 2013 and held it in 15 quarters. The position peaked at $17.7M in Q4 2014. 334 funds tracked by Wall St. Rank hold BHC as of Q4 2018.

Meag Munich Ergo reported no remaining Bausch Health position as of Q4 2018 after selling out during the quarter.
Meag Munich Ergo sold 17,000 Bausch Health shares in Q4 2018, an estimated $424K.
Meag Munich Ergo first reported a position in Bausch Health in Q2 2013 and held it in 15 quarters.
Meag Munich Ergo's Bausch Health position peaked at $17.7M in Q4 2014.
334 funds tracked by Wall St. Rank held Bausch Health as of Q4 2018.

Based on Meag Munich Ergo's 13F filing for Q4 2018, filed 29 Jan 2019.